Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Walmart Shares Likely Facing Short-Term Breather, Oppenheimer Says

Walmart Shares Likely Facing Short-Term Breather, Oppenheimer Says

MT newswireMT newswire2026/08/25 15:17
11:17 AM EDT, 08/25/2026 (MT Newswires) -- Walmart's (WMT) recent share pullback reflects a valuation reset and softer US comparable-sales trends, and the stock's short-term breather is likely to continue, Oppenheimer said Tuesday in a report. US comparable sales slowed both including and excluding Health & Wellness, while General Merchandise trends decelerated from mid-single-digit growth in Q1 to low-single digits in Q2, Oppenheimer said. Shares now trade at about 34 times next-12-month consensus earnings estimates, down from a peak of 44 times, the report said. Oppenheimer sees a bottom for the stock in the low $90s to low $100s and remains focused on upside potential in the US General Merchandise category, which it views as a swing factor. Walmart's management team under CEO John Furner "continues to execute quite well," the report said. Oppenheimer has a perform rating on Walmart stock and said its longer-term upbeat views on the company are unchanged. Price: 105.12, Change: -1.37, Percent Change: -1.29
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"Big Short" Burry opens a position in QXO (QXO.US), betting on building products integration and undervaluation; stock price rises over 7%

Investor Michael Burry disclosed that he has purchased common and preferred shares of QXO (QXO.US), a building products company, citing its integration strategy and the currently depressed stock price. The stock surged 7.2% on Monday.

智通财经2026/09/21 23:36

700,000 new elderly patients join, Eli Lilly (LLY.US) dominates 70%: The first Medicare weight loss drug coverage report released

Dave Ricks, CEO of Eli Lilly (LLY.US), said in an interview on Monday that since Medicare began coverage for obesity drugs in July, 700,000 new elderly patients have started using GLP-1 medications.

智通财经2026/09/21 23:31